Results 41 to 50 of about 12,780 (188)

Resolution of folliculitis decalvans with medical honey [PDF]

open access: yes, 2019
Folliculitis decalvans is a rare scarring alopecia that presents with indurated, tender pustules and papules on the vertex and occipital scalp.
Yasuda, Mariko R   +10 more
core   +1 more source

Large‐Scale Applications of Plasma Technologies: Progresses and Challenges

open access: yesHigh Voltage, EarlyView.
ABSTRACT Plasma technologies convert electrical power into energetic electrons, ions, reactive species, radiation and heat, thereby breaking through the bottleneck of purely thermal or chemical routes and bringing impressive changes to our world. This roadmap reviews the progress and challenges of plasma technologies from a large‐scale and application ...
Pankaj Attri   +51 more
wiley   +1 more source

The Role of Malassezia in Nonscarring Scalp Folliculitis, The Disease Course, and the Treatment Responses: A Retrospective Case Series

open access: yesIndian Journal of Dermatology
Nonscarring scalp folliculitis (NSSF) has been poorly addressed in the literature. Previous studies have focused more on bacterial aetiology. Recent evidence has suggested an inflammatory hypothesis. Data on the role of Malassezia in NSSF are scarce.
Cemile T. Altunel, Meryem Ö. Öztürk
doaj   +1 more source

Post hair removal folliculitis : a clinicopathological evaluation [PDF]

open access: yes, 2023
Folliculitis refers to the process by which a hair follicle becomes inflamed. This has a number of aetiologies, complications and clinical implications. Hair removal is a common cause of folliculitis.
Pace, Leona Marie
core  

Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5‐Year Analysis of the Phase 3 POETYK PSO‐1, PSO‐4, and Long‐Term Extension Trials

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Deucravacitinib, an oral, selective tyrosine kinase 2 inhibitor, is approved in multiple countries for the treatment of moderate to severe plaque psoriasis, as well as generalized pustular and erythrodermic psoriasis in Japan. Deucravacitinib 6 mg once daily was efficacious and well tolerated through 3 years in the pooled population of ...
Yukari Okubo   +12 more
wiley   +1 more source

Foliculitis Decalvans In Siblings

open access: yesIndian Journal of Dermatology, 1997
Folliculitis decalvans is a rare cause of cicatricial alopecia. Apart from a single report by Shitara and co-workers, familial occurrence of folliculitis decalvans has not been reported.
D′Souza Mariette   +2 more
doaj  

Common Superficial Bacterial Skin Infections Self-Reported by 1047 Greek Competitive Swimmers: A 2021 Retrospective Study

open access: yesInfectious Disease Reports
Background/Objectives: Superficial bacterial skin infections are common, particularly among athletes. In swimming, data on folliculitis, impetigo, and pitted keratolysis are limited.
Eleni Sfyri   +4 more
doaj   +1 more source

Therapeutic effect of botulinum toxin A on folliculitis dissecans of the scalp [PDF]

open access: yesSurgical & Cosmetic Dermatology
A patient with dissecting folliculitis of the scalp who did not respond to antibiotic therapy received four monthly sessions of intradermal administration of 100 IU of botulinum toxin A.
Simone Ramos Neri   +5 more
doaj   +1 more source

Folliculitis decalvans: a case report of satisfactory recovery after implementing isotretinoin therapy

open access: yesCase Reports, 2022
Introduction: Folliculitis decalvans is a rare skin disease characterized by the presence of painful papules and pustules with an underlying neutrophilic infiltrate, usually on the scalp.
Julián Felipe Porras-Villamil   +3 more
doaj   +1 more source

Real‐World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan

open access: yesThe Journal of Dermatology, EarlyView.
ABSTRACT Background Tapinarof cream 1%, a non‐steroidal topical aryl hydrocarbon receptor‐modulating agent, is approved in Japan for atopic dermatitis (AD) and plaque psoriasis. Real‐world data on longitudinal outcomes, treatment continuation, interruption and restart, and adverse‐event timing are limited. Methods This single‐center retrospective study
Kanade Iino   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy